A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer

Clinical trial NCT06548672 · RECRUITING

Trial details

NCT number: NCT06548672
Sponsor: Biocity Biopharmaceutics Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Metastatic Solid Tumor

Start date: 2024-06-24
Primary completion: 2027-04-30
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.